nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—PNLIP—Retinoid metabolism and transport—LRP1—migraine	0.0121	0.0553	CbGpPWpGaD
Orlistat—ABHD16A—trigeminal ganglion—migraine	0.0117	0.078	CbGeAlD
Orlistat—ABHD12—trigeminal ganglion—migraine	0.011	0.0731	CbGeAlD
Orlistat—DAGLA—head—migraine	0.00974	0.0649	CbGeAlD
Orlistat—DAGLA—nervous system—migraine	0.00923	0.0616	CbGeAlD
Orlistat—FASN—trigeminal ganglion—migraine	0.0092	0.0614	CbGeAlD
Orlistat—PLA2G7—cardiovascular system—migraine	0.00901	0.0601	CbGeAlD
Orlistat—CYP3A4—Propranolol—migraine	0.00897	0.247	CbGbCtD
Orlistat—DAGLA—central nervous system—migraine	0.00889	0.0593	CbGeAlD
Orlistat—DAGLA—cerebellum—migraine	0.00869	0.0579	CbGeAlD
Orlistat—PNLIP—cardiovascular system—migraine	0.00792	0.0528	CbGeAlD
Orlistat—CYP3A4—Amitriptyline—migraine	0.00776	0.214	CbGbCtD
Orlistat—CYP3A4—Valproic Acid—migraine	0.00707	0.195	CbGbCtD
Orlistat—DAGLA—brain—migraine	0.00706	0.0471	CbGeAlD
Orlistat—PLA2G7—Peptide hormone metabolism—ACE—migraine	0.00678	0.0311	CbGpPWpGaD
Orlistat—DAGLB—cerebellum—migraine	0.00674	0.0449	CbGeAlD
Orlistat—CYP3A4—Topiramate—migraine	0.00638	0.176	CbGbCtD
Orlistat—PNLIP—Diseases associated with visual transduction—LRP1—migraine	0.00617	0.0282	CbGpPWpGaD
Orlistat—CYP3A4—Verapamil—migraine	0.00616	0.169	CbGbCtD
Orlistat—PLA2G4A—p38 MAPK Signaling Pathway—MEF2D—migraine	0.00584	0.0267	CbGpPWpGaD
Orlistat—PLA2G4A—Pindolol—Propranolol—migraine	0.00581	1	CbGdCrCtD
Orlistat—DAGLB—brain—migraine	0.00547	0.0365	CbGeAlD
Orlistat—PNLIP—head—migraine	0.00536	0.0358	CbGeAlD
Orlistat—FASN—Integration of energy metabolism—CACNA1A—migraine	0.00517	0.0237	CbGpPWpGaD
Orlistat—ABHD16A—cerebellum—migraine	0.00511	0.034	CbGeAlD
Orlistat—DAGLA—G alpha (q) signalling events—HTR2B—migraine	0.00492	0.0225	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—HTR2B—migraine	0.00492	0.0225	CbGpPWpGaD
Orlistat—ABHD12—cerebellum—migraine	0.00478	0.0319	CbGeAlD
Orlistat—PLA2G4A—trigeminal ganglion—migraine	0.00442	0.0295	CbGeAlD
Orlistat—PLA2G7—brain—migraine	0.00442	0.0295	CbGeAlD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.0044	0.0201	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.0044	0.0201	CbGpPWpGaD
Orlistat—FASN—cerebellum—migraine	0.00402	0.0268	CbGeAlD
Orlistat—ABHD12—brain—migraine	0.00389	0.0259	CbGeAlD
Orlistat—FASN—brain—migraine	0.00326	0.0217	CbGeAlD
Orlistat—PLA2G4A—cardiovascular system—migraine	0.0032	0.0213	CbGeAlD
Orlistat—PLA2G4A—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.00315	0.0144	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—TAC1—migraine	0.00304	0.0139	CbGpPWpGaD
Orlistat—DAGLA—G alpha (q) signalling events—TAC1—migraine	0.00304	0.0139	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—NPS—migraine	0.00304	0.0139	CbGpPWpGaD
Orlistat—DAGLA—G alpha (q) signalling events—NPS—migraine	0.00304	0.0139	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—HTR2C—migraine	0.00298	0.0136	CbGpPWpGaD
Orlistat—DAGLA—G alpha (q) signalling events—HTR2C—migraine	0.00298	0.0136	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—EDNRA—migraine	0.0029	0.0133	CbGpPWpGaD
Orlistat—DAGLA—G alpha (q) signalling events—EDNRA—migraine	0.0029	0.0133	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.00272	0.0124	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.00272	0.0124	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.00272	0.0124	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.00272	0.0124	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.00267	0.0122	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.00267	0.0122	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00259	0.0119	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00259	0.0119	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CALCRL—migraine	0.00208	0.0095	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—RAMP1—migraine	0.00208	0.0095	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CALCRL—migraine	0.00208	0.0095	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—RAMP1—migraine	0.00208	0.0095	CbGpPWpGaD
Orlistat—PLA2G4A—nervous system—migraine	0.00205	0.0137	CbGeAlD
Orlistat—PLA2G4A—central nervous system—migraine	0.00197	0.0132	CbGeAlD
Orlistat—FASN—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.00197	0.00904	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—RAMP1—migraine	0.00188	0.00863	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CALCRL—migraine	0.00188	0.00863	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CALCRL—migraine	0.00188	0.00863	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—RAMP1—migraine	0.00188	0.00863	CbGpPWpGaD
Orlistat—DAGLA—G alpha (q) signalling events—HTR2A—migraine	0.00183	0.00837	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—HTR2A—migraine	0.00183	0.00837	CbGpPWpGaD
Orlistat—PLA2G4A—Endothelins—EDNRA—migraine	0.00174	0.00797	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.00163	0.00749	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.00163	0.00749	CbGpPWpGaD
Orlistat—PLA2G4A—brain—migraine	0.00157	0.0105	CbGeAlD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—ESR1—migraine	0.00156	0.00714	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—HTR1D—migraine	0.00151	0.0069	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—HTR1D—migraine	0.00151	0.0069	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—LRP1—migraine	0.0015	0.00689	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—HTR2B—migraine	0.0014	0.00642	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—HTR2B—migraine	0.0014	0.00642	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—HTR1D—migraine	0.00137	0.00627	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HTR1D—migraine	0.00137	0.00627	CbGpPWpGaD
Orlistat—PLA2G4A—PDGF Pathway—FOS—migraine	0.00129	0.0059	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—ACE—migraine	0.00128	0.00586	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—HTR2B—migraine	0.00127	0.00583	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HTR2B—migraine	0.00127	0.00583	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—RAMP1—migraine	0.00111	0.0051	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—RAMP1—migraine	0.00111	0.0051	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CALCRL—migraine	0.00111	0.0051	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CALCRL—migraine	0.00111	0.0051	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—RAMP1—migraine	0.000922	0.00422	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CALCRL—migraine	0.000922	0.00422	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—HTR1B—migraine	0.000913	0.00418	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—HTR1B—migraine	0.000913	0.00418	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—FOS—migraine	0.000901	0.00413	CbGpPWpGaD
Orlistat—Malnutrition—Valproic Acid—migraine	0.000893	0.00151	CcSEcCtD
Orlistat—Sinusitis—Gabapentin—migraine	0.000888	0.00151	CcSEcCtD
Orlistat—Urticaria—Propranolol—migraine	0.000887	0.00151	CcSEcCtD
Orlistat—Fatigue—Verapamil—migraine	0.000886	0.0015	CcSEcCtD
Orlistat—Abdominal pain—Propranolol—migraine	0.000883	0.0015	CcSEcCtD
Orlistat—Body temperature increased—Propranolol—migraine	0.000883	0.0015	CcSEcCtD
Orlistat—Flatulence—Valproic Acid—migraine	0.00088	0.00149	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—HTR1A—migraine	0.000879	0.00403	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—HTR1A—migraine	0.000879	0.00403	CbGpPWpGaD
Orlistat—Pain—Verapamil—migraine	0.000879	0.00149	CcSEcCtD
Orlistat—PLA2G4A—Endothelins—FOS—migraine	0.000878	0.00402	CbGpPWpGaD
Orlistat—Pancreatitis—Topiramate—migraine	0.000876	0.00149	CcSEcCtD
Orlistat—Dysgeusia—Valproic Acid—migraine	0.000874	0.00148	CcSEcCtD
Orlistat—Vomiting—Amitriptyline—migraine	0.000872	0.00148	CcSEcCtD
Orlistat—Sweating increased—Topiramate—migraine	0.00087	0.00148	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—TAC1—migraine	0.000866	0.00397	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—TAC1—migraine	0.000866	0.00397	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—NPS—migraine	0.000866	0.00397	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—NPS—migraine	0.000866	0.00397	CbGpPWpGaD
Orlistat—Rash—Amitriptyline—migraine	0.000865	0.00147	CcSEcCtD
Orlistat—Dermatitis—Amitriptyline—migraine	0.000864	0.00147	CcSEcCtD
Orlistat—Back pain—Valproic Acid—migraine	0.000864	0.00146	CcSEcCtD
Orlistat—Headache—Amitriptyline—migraine	0.000859	0.00146	CcSEcCtD
Orlistat—Muscle spasms—Valproic Acid—migraine	0.000858	0.00146	CcSEcCtD
Orlistat—Abdominal discomfort—Topiramate—migraine	0.000857	0.00145	CcSEcCtD
Orlistat—Hepatitis—Gabapentin—migraine	0.00085	0.00144	CcSEcCtD
Orlistat—Haemorrhage—Gabapentin—migraine	0.00085	0.00144	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—HTR2C—migraine	0.000849	0.00389	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—HTR2C—migraine	0.000849	0.00389	CbGpPWpGaD
Orlistat—Feeling abnormal—Verapamil—migraine	0.000847	0.00144	CcSEcCtD
Orlistat—Pharyngitis—Gabapentin—migraine	0.000844	0.00143	CcSEcCtD
Orlistat—Vision blurred—Valproic Acid—migraine	0.000841	0.00143	CcSEcCtD
Orlistat—Urinary tract disorder—Gabapentin—migraine	0.00084	0.00142	CcSEcCtD
Orlistat—Oedema peripheral—Gabapentin—migraine	0.000837	0.00142	CcSEcCtD
Orlistat—PNLIP—Metabolism—CACNA1A—migraine	0.000836	0.00383	CbGpPWpGaD
Orlistat—Urethral disorder—Gabapentin—migraine	0.000833	0.00141	CcSEcCtD
Orlistat—Upper respiratory tract infection—Topiramate—migraine	0.00083	0.00141	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—HTR1B—migraine	0.00083	0.0038	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HTR1B—migraine	0.00083	0.0038	CbGpPWpGaD
Orlistat—Ill-defined disorder—Valproic Acid—migraine	0.000828	0.00141	CcSEcCtD
Orlistat—DAGLB—GPCR downstream signaling—EDNRA—migraine	0.000826	0.00378	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—EDNRA—migraine	0.000826	0.00378	CbGpPWpGaD
Orlistat—Immune system disorder—Timolol—migraine	0.000825	0.0014	CcSEcCtD
Orlistat—Hypersensitivity—Propranolol—migraine	0.000823	0.0014	CcSEcCtD
Orlistat—Mediastinal disorder—Timolol—migraine	0.000823	0.0014	CcSEcCtD
Orlistat—Urticaria—Verapamil—migraine	0.000816	0.00138	CcSEcCtD
Orlistat—Angioedema—Valproic Acid—migraine	0.000816	0.00138	CcSEcCtD
Orlistat—Nausea—Amitriptyline—migraine	0.000815	0.00138	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—HTR1D—migraine	0.000809	0.0037	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HTR1D—migraine	0.000809	0.0037	CbGpPWpGaD
Orlistat—Alopecia—Timolol—migraine	0.000807	0.00137	CcSEcCtD
Orlistat—Malaise—Valproic Acid—migraine	0.000805	0.00137	CcSEcCtD
Orlistat—Vertigo—Valproic Acid—migraine	0.000802	0.00136	CcSEcCtD
Orlistat—Asthenia—Propranolol—migraine	0.000801	0.00136	CcSEcCtD
Orlistat—Mental disorder—Timolol—migraine	0.0008	0.00136	CcSEcCtD
Orlistat—DAGLA—Signaling by GPCR—HTR1A—migraine	0.000799	0.00366	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—HTR1A—migraine	0.000799	0.00366	CbGpPWpGaD
Orlistat—Infestation NOS—Topiramate—migraine	0.000797	0.00135	CcSEcCtD
Orlistat—Infestation—Topiramate—migraine	0.000797	0.00135	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—CALCA—migraine	0.000795	0.00364	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CALCA—migraine	0.000795	0.00364	CbGpPWpGaD
Orlistat—Malnutrition—Timolol—migraine	0.000795	0.00135	CcSEcCtD
Orlistat—Depression—Topiramate—migraine	0.000794	0.00135	CcSEcCtD
Orlistat—Palpitations—Valproic Acid—migraine	0.000789	0.00134	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—TAC1—migraine	0.000786	0.0036	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—TAC1—migraine	0.000786	0.0036	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—NPS—migraine	0.000786	0.0036	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—NPS—migraine	0.000786	0.0036	CbGpPWpGaD
Orlistat—PNLIP—Disease—LRP1—migraine	0.000783	0.00359	CbGpPWpGaD
Orlistat—Renal failure—Topiramate—migraine	0.000783	0.00133	CcSEcCtD
Orlistat—Neuropathy peripheral—Topiramate—migraine	0.000781	0.00132	CcSEcCtD
Orlistat—Cough—Valproic Acid—migraine	0.000779	0.00132	CcSEcCtD
Orlistat—Dysgeusia—Timolol—migraine	0.000778	0.00132	CcSEcCtD
Orlistat—Urinary tract infection—Topiramate—migraine	0.000774	0.00131	CcSEcCtD
Orlistat—DAGLA—Signaling by GPCR—HTR2C—migraine	0.000771	0.00353	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—HTR2C—migraine	0.000771	0.00353	CbGpPWpGaD
Orlistat—Immune system disorder—Gabapentin—migraine	0.000768	0.0013	CcSEcCtD
Orlistat—Mediastinal disorder—Gabapentin—migraine	0.000766	0.0013	CcSEcCtD
Orlistat—Diarrhoea—Propranolol—migraine	0.000764	0.0013	CcSEcCtD
Orlistat—Myalgia—Valproic Acid—migraine	0.00076	0.00129	CcSEcCtD
Orlistat—Chest pain—Valproic Acid—migraine	0.00076	0.00129	CcSEcCtD
Orlistat—Anxiety—Valproic Acid—migraine	0.000757	0.00128	CcSEcCtD
Orlistat—Hypersensitivity—Verapamil—migraine	0.000757	0.00128	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000755	0.00128	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—HTR2B—migraine	0.000752	0.00344	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HTR2B—migraine	0.000752	0.00344	CbGpPWpGaD
Orlistat—Alopecia—Gabapentin—migraine	0.000751	0.00127	CcSEcCtD
Orlistat—Discomfort—Valproic Acid—migraine	0.000751	0.00127	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—EDNRA—migraine	0.00075	0.00344	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—EDNRA—migraine	0.00075	0.00344	CbGpPWpGaD
Orlistat—Vision blurred—Timolol—migraine	0.000749	0.00127	CcSEcCtD
Orlistat—Sinusitis—Topiramate—migraine	0.000747	0.00127	CcSEcCtD
Orlistat—Mental disorder—Gabapentin—migraine	0.000745	0.00126	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—HTR7—migraine	0.000744	0.00341	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—HTR7—migraine	0.000744	0.00341	CbGpPWpGaD
Orlistat—Dry mouth—Valproic Acid—migraine	0.000743	0.00126	CcSEcCtD
Orlistat—Malnutrition—Gabapentin—migraine	0.00074	0.00126	CcSEcCtD
Orlistat—Dizziness—Propranolol—migraine	0.000739	0.00125	CcSEcCtD
Orlistat—Asthenia—Verapamil—migraine	0.000737	0.00125	CcSEcCtD
Orlistat—Flatulence—Gabapentin—migraine	0.000729	0.00124	CcSEcCtD
Orlistat—Anaphylactic shock—Valproic Acid—migraine	0.000729	0.00124	CcSEcCtD
Orlistat—Oedema—Valproic Acid—migraine	0.000729	0.00124	CcSEcCtD
Orlistat—Pruritus—Verapamil—migraine	0.000727	0.00123	CcSEcCtD
Orlistat—Angioedema—Timolol—migraine	0.000726	0.00123	CcSEcCtD
Orlistat—Dysgeusia—Gabapentin—migraine	0.000725	0.00123	CcSEcCtD
Orlistat—Infection—Valproic Acid—migraine	0.000724	0.00123	CcSEcCtD
Orlistat—DAGLA—Signaling by GPCR—CALCA—migraine	0.000722	0.00331	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CALCA—migraine	0.000722	0.00331	CbGpPWpGaD
Orlistat—Haemoglobin—Topiramate—migraine	0.000719	0.00122	CcSEcCtD
Orlistat—Back pain—Gabapentin—migraine	0.000716	0.00121	CcSEcCtD
Orlistat—Hepatitis—Topiramate—migraine	0.000715	0.00121	CcSEcCtD
Orlistat—Haemorrhage—Topiramate—migraine	0.000715	0.00121	CcSEcCtD
Orlistat—Nervous system disorder—Valproic Acid—migraine	0.000715	0.00121	CcSEcCtD
Orlistat—Vertigo—Timolol—migraine	0.000714	0.00121	CcSEcCtD
Orlistat—Muscle spasms—Gabapentin—migraine	0.000712	0.00121	CcSEcCtD
Orlistat—Vomiting—Propranolol—migraine	0.00071	0.0012	CcSEcCtD
Orlistat—Pharyngitis—Topiramate—migraine	0.00071	0.0012	CcSEcCtD
Orlistat—Skin disorder—Valproic Acid—migraine	0.000708	0.0012	CcSEcCtD
Orlistat—Urinary tract disorder—Topiramate—migraine	0.000706	0.0012	CcSEcCtD
Orlistat—Oedema peripheral—Topiramate—migraine	0.000705	0.0012	CcSEcCtD
Orlistat—Hyperhidrosis—Valproic Acid—migraine	0.000704	0.00119	CcSEcCtD
Orlistat—Rash—Propranolol—migraine	0.000704	0.00119	CcSEcCtD
Orlistat—Dermatitis—Propranolol—migraine	0.000704	0.00119	CcSEcCtD
Orlistat—Diarrhoea—Verapamil—migraine	0.000703	0.00119	CcSEcCtD
Orlistat—Palpitations—Timolol—migraine	0.000702	0.00119	CcSEcCtD
Orlistat—Urethral disorder—Topiramate—migraine	0.000701	0.00119	CcSEcCtD
Orlistat—Vision blurred—Gabapentin—migraine	0.000697	0.00118	CcSEcCtD
Orlistat—Cough—Timolol—migraine	0.000693	0.00118	CcSEcCtD
Orlistat—Ill-defined disorder—Gabapentin—migraine	0.000687	0.00116	CcSEcCtD
Orlistat—Dizziness—Verapamil—migraine	0.00068	0.00115	CcSEcCtD
Orlistat—CYP3A4—nervous system—migraine	0.000677	0.00451	CbGeAlD
Orlistat—Myalgia—Timolol—migraine	0.000677	0.00115	CcSEcCtD
Orlistat—Chest pain—Timolol—migraine	0.000677	0.00115	CcSEcCtD
Orlistat—Angioedema—Gabapentin—migraine	0.000676	0.00115	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—HTR7—migraine	0.000675	0.00309	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HTR7—migraine	0.000675	0.00309	CbGpPWpGaD
Orlistat—Anxiety—Timolol—migraine	0.000674	0.00114	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000672	0.00114	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—HTR1D—migraine	0.00067	0.00307	CbGpPWpGaD
Orlistat—Discomfort—Timolol—migraine	0.000668	0.00113	CcSEcCtD
Orlistat—Malaise—Gabapentin—migraine	0.000667	0.00113	CcSEcCtD
Orlistat—Vertigo—Gabapentin—migraine	0.000665	0.00113	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Valproic Acid—migraine	0.000664	0.00113	CcSEcCtD
Orlistat—Nausea—Propranolol—migraine	0.000664	0.00113	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—LRP1—migraine	0.000662	0.00303	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—LRP1—migraine	0.000662	0.00303	CbGpPWpGaD
Orlistat—Dry mouth—Timolol—migraine	0.000662	0.00112	CcSEcCtD
Orlistat—Insomnia—Valproic Acid—migraine	0.000659	0.00112	CcSEcCtD
Orlistat—Paraesthesia—Valproic Acid—migraine	0.000654	0.00111	CcSEcCtD
Orlistat—Palpitations—Gabapentin—migraine	0.000654	0.00111	CcSEcCtD
Orlistat—Vomiting—Verapamil—migraine	0.000653	0.00111	CcSEcCtD
Orlistat—CYP3A4—central nervous system—migraine	0.000651	0.00434	CbGeAlD
Orlistat—Oedema—Timolol—migraine	0.000649	0.0011	CcSEcCtD
Orlistat—Anaphylactic shock—Timolol—migraine	0.000649	0.0011	CcSEcCtD
Orlistat—Rash—Verapamil—migraine	0.000648	0.0011	CcSEcCtD
Orlistat—Dermatitis—Verapamil—migraine	0.000647	0.0011	CcSEcCtD
Orlistat—Immune system disorder—Topiramate—migraine	0.000646	0.0011	CcSEcCtD
Orlistat—Cough—Gabapentin—migraine	0.000646	0.0011	CcSEcCtD
Orlistat—Mediastinal disorder—Topiramate—migraine	0.000645	0.00109	CcSEcCtD
Orlistat—Infection—Timolol—migraine	0.000644	0.00109	CcSEcCtD
Orlistat—Headache—Verapamil—migraine	0.000644	0.00109	CcSEcCtD
Orlistat—Dyspepsia—Valproic Acid—migraine	0.000641	0.00109	CcSEcCtD
Orlistat—Convulsion—Gabapentin—migraine	0.000641	0.00109	CcSEcCtD
Orlistat—Nervous system disorder—Timolol—migraine	0.000636	0.00108	CcSEcCtD
Orlistat—Decreased appetite—Valproic Acid—migraine	0.000633	0.00107	CcSEcCtD
Orlistat—Alopecia—Topiramate—migraine	0.000632	0.00107	CcSEcCtD
Orlistat—Myalgia—Gabapentin—migraine	0.00063	0.00107	CcSEcCtD
Orlistat—Chest pain—Gabapentin—migraine	0.00063	0.00107	CcSEcCtD
Orlistat—Skin disorder—Timolol—migraine	0.00063	0.00107	CcSEcCtD
Orlistat—Gastrointestinal disorder—Valproic Acid—migraine	0.000629	0.00107	CcSEcCtD
Orlistat—Fatigue—Valproic Acid—migraine	0.000628	0.00107	CcSEcCtD
Orlistat—Anxiety—Gabapentin—migraine	0.000628	0.00107	CcSEcCtD
Orlistat—Hyperhidrosis—Timolol—migraine	0.000627	0.00106	CcSEcCtD
Orlistat—Mental disorder—Topiramate—migraine	0.000627	0.00106	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000626	0.00106	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—HTR2B—migraine	0.000623	0.00285	CbGpPWpGaD
Orlistat—Pain—Valproic Acid—migraine	0.000623	0.00106	CcSEcCtD
Orlistat—Malnutrition—Topiramate—migraine	0.000623	0.00106	CcSEcCtD
Orlistat—Discomfort—Gabapentin—migraine	0.000623	0.00106	CcSEcCtD
Orlistat—Dry mouth—Gabapentin—migraine	0.000616	0.00105	CcSEcCtD
Orlistat—Flatulence—Topiramate—migraine	0.000614	0.00104	CcSEcCtD
Orlistat—Nausea—Verapamil—migraine	0.00061	0.00104	CcSEcCtD
Orlistat—Dysgeusia—Topiramate—migraine	0.00061	0.00103	CcSEcCtD
Orlistat—Anaphylactic shock—Gabapentin—migraine	0.000604	0.00102	CcSEcCtD
Orlistat—Oedema—Gabapentin—migraine	0.000604	0.00102	CcSEcCtD
Orlistat—Back pain—Topiramate—migraine	0.000602	0.00102	CcSEcCtD
Orlistat—Feeling abnormal—Valproic Acid—migraine	0.0006	0.00102	CcSEcCtD
Orlistat—Infection—Gabapentin—migraine	0.0006	0.00102	CcSEcCtD
Orlistat—Muscle spasms—Topiramate—migraine	0.000599	0.00102	CcSEcCtD
Orlistat—Gastrointestinal pain—Valproic Acid—migraine	0.000596	0.00101	CcSEcCtD
Orlistat—Nervous system disorder—Gabapentin—migraine	0.000592	0.001	CcSEcCtD
Orlistat—FASN—Metabolism—CACNA1A—migraine	0.000592	0.00271	CbGpPWpGaD
Orlistat—Musculoskeletal discomfort—Timolol—migraine	0.000591	0.001	CcSEcCtD
Orlistat—Vision blurred—Topiramate—migraine	0.000587	0.000995	CcSEcCtD
Orlistat—Skin disorder—Gabapentin—migraine	0.000587	0.000995	CcSEcCtD
Orlistat—Insomnia—Timolol—migraine	0.000587	0.000995	CcSEcCtD
Orlistat—Hyperhidrosis—Gabapentin—migraine	0.000584	0.00099	CcSEcCtD
Orlistat—Paraesthesia—Timolol—migraine	0.000582	0.000988	CcSEcCtD
Orlistat—Urticaria—Valproic Acid—migraine	0.000579	0.000982	CcSEcCtD
Orlistat—Ill-defined disorder—Topiramate—migraine	0.000578	0.00098	CcSEcCtD
Orlistat—Abdominal pain—Valproic Acid—migraine	0.000576	0.000977	CcSEcCtD
Orlistat—Body temperature increased—Valproic Acid—migraine	0.000576	0.000977	CcSEcCtD
Orlistat—Dyspepsia—Timolol—migraine	0.000571	0.000968	CcSEcCtD
Orlistat—Decreased appetite—Timolol—migraine	0.000564	0.000956	CcSEcCtD
Orlistat—Malaise—Topiramate—migraine	0.000561	0.000952	CcSEcCtD
Orlistat—Gastrointestinal disorder—Timolol—migraine	0.00056	0.00095	CcSEcCtD
Orlistat—Vertigo—Topiramate—migraine	0.000559	0.000949	CcSEcCtD
Orlistat—Fatigue—Timolol—migraine	0.000559	0.000949	CcSEcCtD
Orlistat—Pain—Timolol—migraine	0.000555	0.000941	CcSEcCtD
Orlistat—FASN—Disease—LRP1—migraine	0.000554	0.00254	CbGpPWpGaD
Orlistat—Musculoskeletal discomfort—Gabapentin—migraine	0.00055	0.000933	CcSEcCtD
Orlistat—Palpitations—Topiramate—migraine	0.00055	0.000933	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—LRP1—migraine	0.000549	0.00251	CbGpPWpGaD
Orlistat—Insomnia—Gabapentin—migraine	0.000546	0.000927	CcSEcCtD
Orlistat—Cough—Topiramate—migraine	0.000543	0.000922	CcSEcCtD
Orlistat—Paraesthesia—Gabapentin—migraine	0.000542	0.00092	CcSEcCtD
Orlistat—Convulsion—Topiramate—migraine	0.000539	0.000915	CcSEcCtD
Orlistat—Hypersensitivity—Valproic Acid—migraine	0.000537	0.000911	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000535	0.00245	CbGpPWpGaD
Orlistat—Feeling abnormal—Timolol—migraine	0.000534	0.000907	CcSEcCtD
Orlistat—Dyspepsia—Gabapentin—migraine	0.000532	0.000902	CcSEcCtD
Orlistat—Gastrointestinal pain—Timolol—migraine	0.00053	0.0009	CcSEcCtD
Orlistat—Chest pain—Topiramate—migraine	0.00053	0.000899	CcSEcCtD
Orlistat—Myalgia—Topiramate—migraine	0.00053	0.000899	CcSEcCtD
Orlistat—Anxiety—Topiramate—migraine	0.000528	0.000896	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000526	0.000893	CcSEcCtD
Orlistat—Decreased appetite—Gabapentin—migraine	0.000525	0.000891	CcSEcCtD
Orlistat—Discomfort—Topiramate—migraine	0.000524	0.000888	CcSEcCtD
Orlistat—Asthenia—Valproic Acid—migraine	0.000523	0.000887	CcSEcCtD
Orlistat—Gastrointestinal disorder—Gabapentin—migraine	0.000521	0.000885	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—HTR2A—migraine	0.000521	0.00239	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—HTR2A—migraine	0.000521	0.00239	CbGpPWpGaD
Orlistat—Fatigue—Gabapentin—migraine	0.000521	0.000883	CcSEcCtD
Orlistat—Dry mouth—Topiramate—migraine	0.000518	0.000879	CcSEcCtD
Orlistat—Pain—Gabapentin—migraine	0.000517	0.000876	CcSEcCtD
Orlistat—Pruritus—Valproic Acid—migraine	0.000515	0.000874	CcSEcCtD
Orlistat—Urticaria—Timolol—migraine	0.000515	0.000874	CcSEcCtD
Orlistat—Abdominal pain—Timolol—migraine	0.000513	0.00087	CcSEcCtD
Orlistat—Body temperature increased—Timolol—migraine	0.000513	0.00087	CcSEcCtD
Orlistat—Oedema—Topiramate—migraine	0.000508	0.000862	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—NOTCH4—migraine	0.000508	0.00233	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NOTCH4—migraine	0.000508	0.00233	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—FOS—migraine	0.000508	0.00233	CbGpPWpGaD
Orlistat—Infection—Topiramate—migraine	0.000505	0.000856	CcSEcCtD
Orlistat—PNLIP—Disease—CALCA—migraine	0.000505	0.00231	CbGpPWpGaD
Orlistat—Diarrhoea—Valproic Acid—migraine	0.000499	0.000846	CcSEcCtD
Orlistat—Nervous system disorder—Topiramate—migraine	0.000498	0.000845	CcSEcCtD
Orlistat—Feeling abnormal—Gabapentin—migraine	0.000498	0.000844	CcSEcCtD
Orlistat—Gastrointestinal pain—Gabapentin—migraine	0.000494	0.000838	CcSEcCtD
Orlistat—Skin disorder—Topiramate—migraine	0.000494	0.000837	CcSEcCtD
Orlistat—Hyperhidrosis—Topiramate—migraine	0.000491	0.000833	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—HTR1B—migraine	0.00049	0.00224	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HTR1B—migraine	0.00049	0.00224	CbGpPWpGaD
Orlistat—Dizziness—Valproic Acid—migraine	0.000482	0.000817	CcSEcCtD
Orlistat—Urticaria—Gabapentin—migraine	0.00048	0.000814	CcSEcCtD
Orlistat—Hypersensitivity—Timolol—migraine	0.000478	0.000811	CcSEcCtD
Orlistat—Body temperature increased—Gabapentin—migraine	0.000477	0.00081	CcSEcCtD
Orlistat—Abdominal pain—Gabapentin—migraine	0.000477	0.00081	CcSEcCtD
Orlistat—PLA2G4A—Signaling by GPCR—CALCRL—migraine	0.000474	0.00217	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—RAMP1—migraine	0.000474	0.00217	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HTR2A—migraine	0.000473	0.00217	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—HTR2A—migraine	0.000473	0.00217	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HTR1A—migraine	0.000472	0.00216	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HTR1A—migraine	0.000472	0.00216	CbGpPWpGaD
Orlistat—Asthenia—Timolol—migraine	0.000465	0.000789	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—NPS—migraine	0.000465	0.00213	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PGR—migraine	0.000465	0.00213	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NPS—migraine	0.000465	0.00213	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PGR—migraine	0.000465	0.00213	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TAC1—migraine	0.000465	0.00213	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TAC1—migraine	0.000465	0.00213	CbGpPWpGaD
Orlistat—Vomiting—Valproic Acid—migraine	0.000463	0.000786	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Topiramate—migraine	0.000463	0.000785	CcSEcCtD
Orlistat—Insomnia—Topiramate—migraine	0.00046	0.00078	CcSEcCtD
Orlistat—Rash—Valproic Acid—migraine	0.000459	0.000779	CcSEcCtD
Orlistat—Dermatitis—Valproic Acid—migraine	0.000459	0.000779	CcSEcCtD
Orlistat—Pruritus—Timolol—migraine	0.000459	0.000778	CcSEcCtD
Orlistat—Headache—Valproic Acid—migraine	0.000456	0.000774	CcSEcCtD
Orlistat—Paraesthesia—Topiramate—migraine	0.000456	0.000774	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—HTR2C—migraine	0.000456	0.00209	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HTR2C—migraine	0.000456	0.00209	CbGpPWpGaD
Orlistat—Dyspepsia—Topiramate—migraine	0.000447	0.000759	CcSEcCtD
Orlistat—Hypersensitivity—Gabapentin—migraine	0.000445	0.000755	CcSEcCtD
Orlistat—Diarrhoea—Timolol—migraine	0.000444	0.000753	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—EDNRA—migraine	0.000443	0.00203	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—EDNRA—migraine	0.000443	0.00203	CbGpPWpGaD
Orlistat—Decreased appetite—Topiramate—migraine	0.000442	0.000749	CcSEcCtD
Orlistat—Gastrointestinal disorder—Topiramate—migraine	0.000439	0.000744	CcSEcCtD
Orlistat—Fatigue—Topiramate—migraine	0.000438	0.000743	CcSEcCtD
Orlistat—Pain—Topiramate—migraine	0.000435	0.000737	CcSEcCtD
Orlistat—Asthenia—Gabapentin—migraine	0.000433	0.000735	CcSEcCtD
Orlistat—Nausea—Valproic Acid—migraine	0.000433	0.000734	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—NOTCH3—migraine	0.000432	0.00198	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NOTCH3—migraine	0.000432	0.00198	CbGpPWpGaD
Orlistat—Dizziness—Timolol—migraine	0.000429	0.000728	CcSEcCtD
Orlistat—Pruritus—Gabapentin—migraine	0.000427	0.000725	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—CALCA—migraine	0.000427	0.00195	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CALCA—migraine	0.000427	0.00195	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NOTCH4—migraine	0.000421	0.00193	CbGpPWpGaD
Orlistat—Feeling abnormal—Topiramate—migraine	0.000419	0.00071	CcSEcCtD
Orlistat—Gastrointestinal pain—Topiramate—migraine	0.000416	0.000705	CcSEcCtD
Orlistat—Diarrhoea—Gabapentin—migraine	0.000413	0.000701	CcSEcCtD
Orlistat—Vomiting—Timolol—migraine	0.000412	0.0007	CcSEcCtD
Orlistat—Rash—Timolol—migraine	0.000409	0.000694	CcSEcCtD
Orlistat—Dermatitis—Timolol—migraine	0.000409	0.000693	CcSEcCtD
Orlistat—PNLIP—Disease—TGFBR2—migraine	0.000407	0.00186	CbGpPWpGaD
Orlistat—Headache—Timolol—migraine	0.000406	0.000689	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—HTR1B—migraine	0.000406	0.00186	CbGpPWpGaD
Orlistat—Urticaria—Topiramate—migraine	0.000404	0.000685	CcSEcCtD
Orlistat—Body temperature increased—Topiramate—migraine	0.000402	0.000681	CcSEcCtD
Orlistat—Abdominal pain—Topiramate—migraine	0.000402	0.000681	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000401	0.00184	CbGpPWpGaD
Orlistat—Dizziness—Gabapentin—migraine	0.000399	0.000678	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—HTR7—migraine	0.000399	0.00183	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HTR7—migraine	0.000399	0.00183	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HTR1A—migraine	0.000391	0.00179	CbGpPWpGaD
Orlistat—Nausea—Timolol—migraine	0.000385	0.000654	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—PGR—migraine	0.000385	0.00176	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NPS—migraine	0.000385	0.00176	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TAC1—migraine	0.000385	0.00176	CbGpPWpGaD
Orlistat—Vomiting—Gabapentin—migraine	0.000384	0.000651	CcSEcCtD
Orlistat—Rash—Gabapentin—migraine	0.000381	0.000646	CcSEcCtD
Orlistat—Dermatitis—Gabapentin—migraine	0.00038	0.000645	CcSEcCtD
Orlistat—Headache—Gabapentin—migraine	0.000378	0.000642	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—HTR2C—migraine	0.000377	0.00173	CbGpPWpGaD
Orlistat—Hypersensitivity—Topiramate—migraine	0.000374	0.000635	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—EDNRA—migraine	0.000367	0.00168	CbGpPWpGaD
Orlistat—Asthenia—Topiramate—migraine	0.000365	0.000618	CcSEcCtD
Orlistat—Pruritus—Topiramate—migraine	0.00036	0.00061	CcSEcCtD
Orlistat—Nausea—Gabapentin—migraine	0.000359	0.000609	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—NOTCH3—migraine	0.000358	0.00164	CbGpPWpGaD
Orlistat—FASN—Disease—CALCA—migraine	0.000357	0.00164	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CALCA—migraine	0.000353	0.00162	CbGpPWpGaD
Orlistat—Diarrhoea—Topiramate—migraine	0.000348	0.00059	CcSEcCtD
Orlistat—PLA2G4A—Signaling by GPCR—HTR1D—migraine	0.000344	0.00158	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TGFBR2—migraine	0.000344	0.00157	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TGFBR2—migraine	0.000344	0.00157	CbGpPWpGaD
Orlistat—Dizziness—Topiramate—migraine	0.000336	0.00057	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—HTR7—migraine	0.000331	0.00151	CbGpPWpGaD
Orlistat—PNLIP—Disease—MTHFR—migraine	0.00033	0.00151	CbGpPWpGaD
Orlistat—Vomiting—Topiramate—migraine	0.000323	0.000548	CcSEcCtD
Orlistat—Rash—Topiramate—migraine	0.00032	0.000544	CcSEcCtD
Orlistat—PLA2G4A—Signaling by GPCR—HTR2B—migraine	0.00032	0.00147	CbGpPWpGaD
Orlistat—Dermatitis—Topiramate—migraine	0.00032	0.000543	CcSEcCtD
Orlistat—Headache—Topiramate—migraine	0.000318	0.00054	CcSEcCtD
Orlistat—Nausea—Topiramate—migraine	0.000302	0.000512	CcSEcCtD
Orlistat—FASN—Disease—TGFBR2—migraine	0.000288	0.00132	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TGFBR2—migraine	0.000285	0.0013	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RAMP1—migraine	0.00028	0.00128	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CALCRL—migraine	0.00028	0.00128	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HTR2A—migraine	0.000279	0.00128	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HTR2A—migraine	0.000279	0.00128	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—MTHFR—migraine	0.000277	0.00127	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CACNA1A—migraine	0.000254	0.00116	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—ESR1—migraine	0.000248	0.00114	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—ESR1—migraine	0.000248	0.00114	CbGpPWpGaD
Orlistat—FASN—Disease—MTHFR—migraine	0.000234	0.00107	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HTR2A—migraine	0.000232	0.00106	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR1B—migraine	0.000209	0.000956	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ESR1—migraine	0.000206	0.000941	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR1D—migraine	0.000203	0.000932	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR1A—migraine	0.000201	0.00092	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—TAC1—migraine	0.000198	0.000906	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—NPS—migraine	0.000198	0.000906	CbGpPWpGaD
Orlistat—FASN—Metabolism—MTHFR—migraine	0.000196	0.000896	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—migraine	0.000194	0.00089	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR2C—migraine	0.000194	0.000889	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR2B—migraine	0.000189	0.000866	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—EDNRA—migraine	0.000189	0.000864	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CALCA—migraine	0.000182	0.000832	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR7—migraine	0.00017	0.000778	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—LRP1—migraine	0.000167	0.000763	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOTCH4—migraine	0.000128	0.000585	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR1B—migraine	0.000123	0.000565	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR2A—migraine	0.000119	0.000545	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR1A—migraine	0.000119	0.000543	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NPS—migraine	0.000117	0.000535	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PGR—migraine	0.000117	0.000535	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TAC1—migraine	0.000117	0.000535	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR2C—migraine	0.000115	0.000525	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EDNRA—migraine	0.000111	0.000511	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NOTCH3—migraine	0.000109	0.000498	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CALCA—migraine	0.000107	0.000491	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR7—migraine	0.0001	0.00046	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TGFBR2—migraine	8.65e-05	0.000396	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MTHFR—migraine	8.4e-05	0.000385	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR2A—migraine	7.03e-05	0.000322	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ESR1—migraine	6.24e-05	0.000286	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CACNA1A—migraine	5.94e-05	0.000272	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MTHFR—migraine	1.97e-05	9.01e-05	CbGpPWpGaD
